X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
diabetes (5) 5
endocrinology & metabolism (5) 5
insulin (5) 5
diabetes mellitus, type 2 - drug therapy (4) 4
humans (4) 4
hypoglycemic agents - administration & dosage (4) 4
index medicus (4) 4
insulin, long-acting - administration & dosage (4) 4
middle aged (4) 4
type 2 diabetes (4) 4
algorithms (3) 3
diabetes mellitus (3) 3
diabetes mellitus, type 2 - blood (3) 3
drug combinations (3) 3
female (3) 3
glargine (3) 3
glucose (3) 3
glycated hemoglobin a - metabolism (3) 3
hypoglycemia (3) 3
hypoglycemic agents - therapeutic use (3) 3
insulin, long-acting - adverse effects (3) 3
male (3) 3
adult (2) 2
adults (2) 2
aged (2) 2
analysis (2) 2
basal insulin (2) 2
blood glucose - metabolism (2) 2
cohort studies (2) 2
degludec/insulin aspart (2) 2
drug administration schedule (2) 2
endocrinology (2) 2
glycemic control (2) 2
hyperglycemia (2) 2
hypoglycemia - chemically induced (2) 2
hypoglycemic agents - adverse effects (2) 2
insulin degludec (2) 2
insulin, long-acting - therapeutic use (2) 2
management (2) 2
medicine & public health (2) 2
research (2) 2
therapy (2) 2
treatment outcome (2) 2
trial (2) 2
type-2 (2) 2
26-week (1) 1
adherence (1) 1
administration, oral (1) 1
angina pectoris (1) 1
articles (1) 1
aspart (1) 1
autoimmune diseases (1) 1
basal (1) 1
basal-bolus treatment (1) 1
blood glucose - drug effects (1) 1
blood glucose self-monitoring (1) 1
blood sugar (1) 1
brief report (1) 1
cardiology (1) 1
clinical medicine (1) 1
clinical outcomes (1) 1
clinical science and care (1) 1
clinical trial (1) 1
clinical trials (1) 1
clinical trials, phase iii as topic (1) 1
co-formulation (1) 1
comparative analysis (1) 1
complications (1) 1
costs and cost analysis (1) 1
dextrose (1) 1
diabetes mellitus, type 1 - blood (1) 1
diabetes mellitus, type 1 - drug therapy (1) 1
diabetes mellitus, type 1 - economics (1) 1
diabetes mellitus, type 2 - economics (1) 1
diabetes mellitus, type 2 - metabolism (1) 1
dipeptidyl-peptidase iv inhibitors - administration & dosage (1) 1
dipeptidyl-peptidase iv inhibitors - adverse effects (1) 1
dipeptidyl-peptidase iv inhibitors - economics (1) 1
dipeptidyl-peptidase iv inhibitors - therapeutic use (1) 1
dose-response relationship, drug (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
drug therapy, combination - adverse effects (1) 1
drug therapy, combination - economics (1) 1
emergency medical care (1) 1
european association (1) 1
flexibility (1) 1
glycosylated hemoglobin (1) 1
health care costs (1) 1
hemoglobin (1) 1
hypoglycemia - economics (1) 1
hypoglycemia - physiopathology (1) 1
hypoglycemia - therapy (1) 1
hypoglycemic agents - economics (1) 1
immunology (1) 1
insulin aspart (1) 1
insulin aspart - administration & dosage (1) 1
insulin aspart - adverse effects (1) 1
insulin aspart - economics (1) 1
insulin aspart - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetic Medicine, ISSN 0742-3071, 04/2016, Volume 33, Issue 4, pp. 471 - 477
Aims To assess resource utilization associated with severe hypoglycaemia across three insulin regimens in a large phase 3a clinical programme involving people... 
GLYCEMIC CONTROL | 26-WEEK | GLARGINE | NAIVE PATIENTS | ENDOCRINOLOGY & METABOLISM | NON-INFERIORITY TRIAL | OPEN-LABEL | TO-TARGET TRIAL | BASAL-BOLUS TREATMENT | TYPE-2 | DEGLUDEC/INSULIN ASPART | Hypoglycemia - therapy | Hypoglycemic Agents - economics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Insulin Detemir - therapeutic use | Insulin Detemir - economics | Clinical Trials, Phase III as Topic | Hypoglycemic Agents - administration & dosage | Hypoglycemic Agents - therapeutic use | Sitagliptin Phosphate - administration & dosage | Costs and Cost Analysis | Administration, Oral | Drug Therapy, Combination - economics | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Insulin Aspart - economics | Insulin, Long-Acting - adverse effects | Insulin, Long-Acting - administration & dosage | Diabetes Mellitus, Type 1 - economics | Diabetes Mellitus, Type 1 - blood | Insulin, Long-Acting - therapeutic use | Hypoglycemic Agents - adverse effects | Insulin Aspart - adverse effects | Cohort Studies | Insulin Aspart - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Diabetes Mellitus, Type 2 - economics | Insulin, Long-Acting - economics | Dipeptidyl-Peptidase IV Inhibitors - economics | Insulin Glargine - administration & dosage | Drug Therapy, Combination - adverse effects | Insulin Aspart - administration & dosage | Insulin Detemir - administration & dosage | Insulin Detemir - adverse effects | Hypoglycemia - physiopathology | Adult | Hypoglycemia - economics | Hypoglycemia - chemically induced | Severity of Illness Index | Insulin Glargine - adverse effects | Drug Administration Schedule | Insulin Glargine - economics | Insulin Glargine - therapeutic use | Sitagliptin Phosphate - economics | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - blood | Health Care Costs | Sitagliptin Phosphate - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Drug Combinations | Sitagliptin Phosphate - adverse effects | Type 2 diabetes | Adults | Type 1 diabetes | Insulin | Analysis | Emergency medical care | Diabetes | Hypoglycemia | Complications | Research
Journal Article
ENDOCRINE PRACTICE, ISSN 1530-891X, 05/2016, Volume 22, Issue 5, pp. 546 - 554
Objective: This 26-week, multicenter, randomized, open-label, parallel-group, treat-to-target trial in adults with type 2 diabetes compared the efficacy and... 
TRIAL | HYPERGLYCEMIA | MANAGEMENT | GLARGINE | THERAPY | ASPART | PATIENT-CENTERED APPROACH | GLUCOSE | ENDOCRINOLOGY & METABOLISM | TYPE-2 | BASAL
Journal Article
DIABETIC MEDICINE, ISSN 0742-3071, 02/2017, Volume 34, Issue 2, pp. 174 - 179
AimsTo compare the efficacy and safety of two titration algorithms for insulin degludec/insulin aspart (IDegAsp) administered once daily with metformin in... 
TRIAL | ADULTS | REGIMEN | GLUCOSE | ENDOCRINOLOGY & METABOLISM
Journal Article
Journal Article
Diabetes Therapy, ISSN 1869-6953, 2/2017, Volume 8, Issue 1, pp. 197 - 205
In a preceding trial comparing two different titration schemes, insulin degludec/insulin aspart (IDegAsp) showed good efficacy for achieving HbA1c <7% when... 
Glycemic control | Medicine & Public Health | Insulin degludec/insulin aspart | Internal Medicine | Diabetes | Cardiology | Insulin intensification | Endocrinology | CO-FORMULATION | DEGLUDEC/INSULIN ASPART | ENDOCRINOLOGY & METABOLISM | Drug therapy | Insulin | Clinical outcomes | Brief Report | Insulin degludec | insulin aspart
Journal Article
Diabetology International, ISSN 2190-1678, 3/2017, Volume 8, Issue 1, pp. 87 - 94
Managing insulin therapy is a challenge for both patients and healthcare providers.The primary aim of this trial was to compare the efficacy and safety of... 
Type 2 diabetes | Basal insulin | Medicine & Public Health | Titration algorithm | Metabolic Diseases | Diabetes | Insulin degludec | Endocrinology
Journal Article
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, ISSN 1530-891X, 05/2016, Volume 22, Issue 5, pp. 546 - 554
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.